Regenerative cell therapy is a major next step in medical research, with the potential to effectively treat the most complex diseases – including various forms of cancer. Researchers studying regenerative cell therapy look at both how stem cells may be used to replace, repair, reprogram or renew your diseased cells, and at how reprogrammed stem cells may be turned into specialized cells that can repair or regenerate cells. It has the potential to change the outcomes for patients who are left with little time and very few answers. In regenerative cell therapy, function is restored in damaged or destroyed tissues, rather than producing a new organ. This can be done either by intravenously injecting cells into damaged tissue or by inducing self-repair by recruiting from the patient’s own highly functioning tissues. There are a few different types of cells with various effects used in regenerative cell therapy, including: Induced pluripotent stem cells (iPSCs) – Cells that are taken from adult tissue and are genetically altered to behave like an embryonic cell. Embryonic stem cells (ESCs) – Cells that are taken from the inner mass of a blastocyst and have the potential to become any kind of tissue within the body.